DuPont de Nemours (NYSE:DD - Get Free Report) had its target price hoisted by equities research analysts at Wells Fargo & Company from $166.00 to $170.00 in a note issued to investors on Thursday, Benzinga reports. The firm currently has an "overweight" rating on the basic materials company's stock. Wells Fargo & Company's target price suggests a potential upside of 14.40% from the company's current price.
DD has been the topic of a number of other reports. UBS Group lifted their price objective on shares of DuPont de Nemours from $172.00 to $182.00 and gave the company a "buy" rating in a research report on Wednesday. Zacks Research downgraded shares of DuPont de Nemours from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 17th. Barclays raised their target price on shares of DuPont de Nemours from $156.00 to $176.00 and gave the stock an "overweight" rating in a research note on Wednesday. Weiss Ratings reaffirmed a "sell (d+)" rating on shares of DuPont de Nemours in a report on Friday, October 30th. Finally, The Goldman Sachs Group dropped their price target on shares of DuPont de Nemours from $159.00 to $153.00 and set a "neutral" rating on the stock in a research note on Wednesday, September 30th. Twelve equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, DuPont de Nemours has a consensus rating of "Moderate Buy" and a consensus price target of $165.06.
View Our Latest Report on DD
DuPont de Nemours Trading Down 1.4%
Shares of NYSE DD traded down $2.13 during mid-day trading on Thursday, reaching $148.60. 495,402 shares of the company's stock were exchanged, compared to its average volume of 1,345,993. The firm has a market capitalization of $20.07 billion, a price-to-earnings ratio of 66.64, a PEG ratio of 1.37 and a beta of 1.06. DuPont de Nemours has a 52-week low of $111.15 and a 52-week high of $157.98. The company's 50-day moving average is $132.93 and its 200-day moving average is $138.62. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.82 and a current ratio of 2.36.
DuPont de Nemours (NYSE:DD - Get Free Report) last released its quarterly earnings results on Tuesday, November 3rd. The basic materials company reported $2.09 EPS for the quarter, topping analysts' consensus estimates of $1.87 by $0.22. DuPont de Nemours had a return on equity of 6.85% and a net margin of 4.26%. The company had revenue of $1.87 billion for the quarter, compared to analysts' expectations of $1.84 billion. During the same period in the prior year, the firm earned $1.09 earnings per share. The firm's revenue was up 4.1% compared to the same quarter last year. Analysts expect that DuPont de Nemours will post 7.49 EPS for the current fiscal year.
Hedge Funds Weigh In On DuPont de Nemours
A number of institutional investors and hedge funds have recently modified their holdings of DD. State Street Corp grew its holdings in shares of DuPont de Nemours by 140.3% during the second quarter. State Street Corp now owns 44,941,824 shares of the basic materials company's stock valued at $6,095,909,000 after buying an additional 26,238,300 shares during the last quarter. KBC Group NV raised its holdings in shares of DuPont de Nemours by 435.8% in the 1st quarter. KBC Group NV now owns 1,687,376 shares of the basic materials company's stock worth $77,281,000 after acquiring an additional 1,372,435 shares during the last quarter. TD Waterhouse Canada Inc. raised its holdings in shares of DuPont de Nemours by 7,762.1% in the 3rd quarter. TD Waterhouse Canada Inc. now owns 949,117 shares of the basic materials company's stock worth $123,281,000 after acquiring an additional 937,045 shares during the last quarter. Bank of America Corp DE lifted its position in DuPont de Nemours by 22.0% in the 1st quarter. Bank of America Corp DE now owns 4,629,671 shares of the basic materials company's stock valued at $212,039,000 after acquiring an additional 835,572 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership bought a new position in DuPont de Nemours in the 1st quarter valued at about $34,727,000. Institutional investors and hedge funds own 73.96% of the company's stock.
Key Stories Impacting DuPont de Nemours
Here are the key news stories impacting DuPont de Nemours this week:
- Positive Sentiment: Strong quarterly results and higher guidance: DuPont exceeded analysts’ third-quarter earnings and revenue estimates, with adjusted EPS up 62% year over year. The company also raised its full-year 2026 outlook again, supporting expectations for continued growth. Article: DD Q3 Earnings Beat on Organic Growth, Raises 2026 Outlook
- Positive Sentiment: Analysts lifted their targets: UBS raised its target to $182 and maintained a Buy rating; Citigroup and Barclays raised theirs to $176, with Buy and Overweight ratings, respectively. Wells Fargo also increased its target, to $170 from $166. These revisions signal improved analyst confidence. Article: UBS price-target update Article: Wells Fargo price-target update
- Positive Sentiment: Potential shareholder returns: Coverage of the earnings report also noted plans for additional buybacks, which could provide further support for the shares. Article: DD Q3 earnings and outlook
DuPont de Nemours Company Profile
(
Get Free Report)
DuPont de Nemours, Inc is a diversified science and technology company that develops engineered materials and specialty products for industrial and consumer markets. Its offerings are used in applications including electronics, semiconductor manufacturing, water purification, transportation, construction, healthcare, and worker and consumer protection.
The company's product portfolio has historically included high-performance films, resins, adhesives, engineered polymers, specialty fibers, protective materials, water-treatment membranes, and filtration technologies.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DuPont de Nemours, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DuPont de Nemours wasn't on the list.
While DuPont de Nemours currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.